Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Vitamins E & C

This article was originally published in The Tan Sheet

Executive Summary

Vitamins E & C: Researchers at the University of Munich show concomitant oral doses of vitamins C and E provide a protective effect against sunburn. Their study, published in the January issue of the Journal of American Academy of Dermatology, involved 20 subjects: 10 given placebo and 10 given 2 g vitamin C and 1,000 IU vitamin E. The subjects were exposed to UV doses at baseline and after eight days to determine their threshold for UV radiation (MED). The researchers found that the vitamin group's median MED increased from 80 to 96.5 mJ/cm2 while the MED declined in the placebo group from 80 to 68.5 mJ/cm2. "Combined vitamins C and E reduce the sunburn reaction, which might indicate a consequent reduced risk for later sequelae [i.e., skin cancer] of UV-induced skin damage," the researchers conclude...

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

People In Brief

Perrigo promotes in pricing, planning

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088064

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel